Page last updated: 2024-08-22

tetrahydropapaveroline and Idiopathic Parkinson Disease

tetrahydropapaveroline has been researched along with Idiopathic Parkinson Disease in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's3 (30.00)18.2507
2000's4 (40.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Esch, T; Králíčková, M; Kream, RM; Kuzelova, H; Mantione, KJ; Ptacek, R; Stefano, GB1
Collins, MA1
Blarzino, C; Cini, C; Coccia, R; De Marco, F; Foppoli, C; Marcante, ML; Perluigi, M1
Kim, MN; Kim, YM; Lee, JJ; Lee, MK1
Hermida-Ameijeiras, A; Méndez-Alvarez, E; Sánchez-Iglesias, S; Sánchez-Sellero, I; Sanmartín-Suárez, C; Soto-Otero, R1
Cashaw, JL1
Burke, W; Coscia, CJ; Jamroz, G; Lasala, JM; McFarlane, J; Mitchell, J; O'Toole, MM; Wilson, ML1
Akane, A; Fukushima, S; Kobayashi, S; Matsubara, K; Shiono, H1
Mizuno, Y; Suzuki, K; Yoshida, M1
Cashaw, JL; Geraghty, CA1

Reviews

1 review(s) available for tetrahydropapaveroline and Idiopathic Parkinson Disease

ArticleYear
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit.
    Medical science monitor : international medical journal of experimental and clinical research, 2012, Volume: 18, Issue:8

    Topics: Animals; Codeine; Humans; Levodopa; Morphine; Parkinson Disease; Tetrahydropapaveroline

2012

Other Studies

9 other study(ies) available for tetrahydropapaveroline and Idiopathic Parkinson Disease

ArticleYear
Tetrahydropapaveroline in Parkinson's disease and alcoholism: a look back in honor of Merton Sandler.
    Neurotoxicology, 2004, Volume: 25, Issue:1-2

    Topics: Alcoholism; Animals; History, 20th Century; History, 21st Century; Humans; Parkinson Disease; Tetrahydropapaveroline

2004
Ectopic deposition of melanin pigments as detoxifying mechanism: a paradigm for basal nuclei pigmentation.
    Biochemical and biophysical research communications, 2004, Feb-06, Volume: 314, Issue:2

    Topics: Antioxidants; Blotting, Northern; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Cytoplasm; Formamides; Glutathione Peroxidase; HeLa Cells; Humans; Keratinocytes; Melanins; Models, Chemical; Parkinson Disease; Peroxidases; RNA; RNA, Messenger; Superoxide Dismutase; Tetrahydropapaveroline; Time Factors; Transfection; Ultraviolet Rays

2004
Inhibition of dopamine biosynthesis by tetrahydropapaveroline.
    Neuroscience letters, 2005, Sep-23, Volume: 386, Issue:1

    Topics: Adrenal Medulla; Animals; Antioxidants; Cattle; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Levodopa; Nerve Degeneration; Neurons; Oxidative Stress; Parkinson Disease; PC12 Cells; Rats; Tetrahydropapaveroline; Tyrosine 3-Monooxygenase; Up-Regulation

2005
Study on the ability of 1,2,3,4-tetrahydropapaveroline to cause oxidative stress: Mechanisms and potential implications in relation to parkinson's disease.
    Journal of biochemical and molecular toxicology, 2006, Volume: 20, Issue:5

    Topics: Animals; Brain; In Vitro Techniques; Lipid Peroxidation; Male; Mitochondria; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Protein Carbonylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sulfhydryl Compounds; Tetrahydropapaveroline

2006
Determination of tetrahydropapaveroline in the urine of parkinsonian patients receiving L-dopa-carbidopa (Sinemet) therapy by high-performance liquid chromatography.
    Journal of chromatography, 1993, Apr-02, Volume: 613, Issue:2

    Topics: Adsorption; Aluminum Oxide; Antiparkinson Agents; Carbidopa; Cation Exchange Resins; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Drug Combinations; Electrochemistry; Humans; Levodopa; Parkinson Disease; Resins, Synthetic; Silanes; Tetrahydropapaveroline

1993
Occurrence of a new class of tetrahydroisoquinoline alkaloids in L-dopa-treated parkinsonian patients.
    Nature, 1977, Oct-13, Volume: 269, Issue:5629

    Topics: Animals; Biotransformation; Brain; Carbidopa; Catechols; Humans; Levodopa; Mice; Papaverine; Parkinson Disease; Rats; Tetrahydropapaveroline

1977
Increased urinary morphine, codeine and tetrahydropapaveroline in parkinsonian patient undergoing L-3,4-dihydroxyphenylalanine therapy: a possible biosynthetic pathway of morphine from L-3,4-dihydroxyphenylalanine in humans.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:3

    Topics: Adult; Alcohol Drinking; Codeine; Humans; Levodopa; Male; Morphine; Pain; Parkinson Disease; Tetrahydropapaveroline

1992
Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain.
    Neurochemical research, 1990, Volume: 15, Issue:7

    Topics: Adenosine Triphosphate; Animals; Brain; Glutamates; Glutamic Acid; Humans; Isoquinolines; Malates; Male; Mice; Mice, Inbred C57BL; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Oxygen Consumption; Parkinson Disease; Pyruvates; Pyruvic Acid; Quinone Reductases; Tetrahydroisoquinolines; Tetrahydropapaveroline

1990
Method for the identification of tetrahydropapaveroline using the Pictet-Spengler condensation reaction and high-performance liquid chromatography.
    Journal of chromatography, 1989, Apr-14, Volume: 489, Issue:2

    Topics: Animals; Brain Chemistry; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Papaverine; Parkinson Disease; Rats; Tetrahydropapaveroline

1989